Drug Shortage Report for ACT ENALAPRIL

Last updated on 2021-05-10 History
Report ID 134743
Drug Identification Number 02291894
Brand name ACT ENALAPRIL
Common or Proper name ENALAPRIL 10MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ENALAPRIL SODIUM
Strength(s) 8MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-02-23
Estimated end date 2021-05-31
Actual end date
Shortage status Actual shortage
Updated date 2021-05-10
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-05-10 French Compare
v5 2021-05-10 English Compare
v4 2021-05-06 French Compare
v3 2021-05-06 English Compare
v2 2021-02-25 French Compare
v1 2021-02-25 English Compare